Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes

Published:2018-03 Issue:11 Volume:71 Page:1231-1242
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Gargiulo Giuseppe,Carrara Greta,Frigoli Enrico,Vranckx Pascal,Leonardi Sergio,Ciociano Nestor,Campo Gianluca,Varbella Ferdinando,Calabrò Paolo,Garducci Stefano,Iannone Alessandro,Briguori Carlo,Andò Giuseppe,Crimi Gabriele,Limbruno Ugo,Garbo Roberto,Sganzerla Paolo,Russo Filippo,Lupi Alessandro,Cortese Bernardo,Ausiello Arturo,Ierna Salvatore,Esposito Giovanni,Zavalloni Dennis,Santarelli Andrea,Sardella Gennaro,Tresoldi Simone,de Cesare Nicoletta,Sciahbasi Alessandro,Zingarelli Antonio,Tosi Paolo,van ’t Hof Arnoud,Omerovic Elmir,Brugaletta Salvatore,Windecker Stephan,Valgimigli Marco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Bivalirudin or unfractionated heparin in acute coronary syndromes;Valgimigli;N Engl J Med,2015

2. Developing drugs for use before, during and soon after percutaneous coronary intervention;Gargiulo;Expert Opin Pharmacother,2016

3. Procedural anticoagulation in myocardial infarction;Stone;N Engl J Med,2017

4. Bivalirudin in current practice: melius abundare quam deficere?;Valgimigli;J Am Coll Cardiol Intv,2016

5. Bivalirudin started during emergency transport for primary PCI;Steg;N Engl J Med,2013

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The enigma of the ‘smoker's paradox’: Results from a single-center registry of patients with STEMI undergoing primary percutaneous coronary intervention;Cardiovascular Revascularization Medicine;2024-06

2. Why to Study Peptides from Venomous and Poisonous Animals?;International Journal of Peptide Research and Therapeutics;2023-07-14

3. Bivalirudin versus Heparin on Net Adverse Clinical Events, Major Adverse Cardiac and Cerebral Events, and Bleeding in Elderly Chinese Patients Treated with Percutaneous Coronary Intervention;The Tohoku Journal of Experimental Medicine;2023

4. Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study;BMC Cardiovascular Disorders;2022-06-25

5. Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors;Nature Communications;2021-11-25